Gelonghui February 20 丨Huadong Pharmaceutical (000963.SZ) stated during on-site investigation by the agency at 14:30-16:00 on February 15, 2023; 11:00-11:40 and 14:00-15:00 on February 16, that Cool Snow Glacial Spa®It officially entered the domestic market in March last year. Due to the impact of the epidemic and supply chain delivery volume factors, the current revenue share is not high.

The company's relevant teams are also actively developing their business this year, and it is expected that the product will perform better this year. This year, the company introduced Irish EMA's facial skin care device Préime DermaFacial, which is expected to be marketed in China. Viora's wholly-owned medical and aesthetic subsidiary Viora's Reaction™It will also re-enter the Chinese market. The company has set up a dedicated sales promotion team and formulated an overall market positioning and marketing plan for each product. As the impact of the epidemic gradually decreases, the company will strive to achieve positive results in the promotion of optoelectronic medical and aesthetic products in the domestic market this year.